Global Periodontal Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431610
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • 3M
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Galderma S.A.
  • MORE
Periodontal Therapeutics Market - (Treatment Type - Systematic Antibiotics: Doxycycline, Minocycline, Metronidazole, and Others; Local Antibiotics: Arestin, Chlorhexidine, and Others): Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the market was valued at US$ 259.5 Mn in 2016, and is expected to reach US$ 580.5 Mn by 2025, expanding at a CAGR of 9.2% from 2017 to 2025.

Market Insights

Periodontal therapeutics are the non-surgical treatment for the periodontal diseases. Periodontal diseases are the infections of the structures around the teeth including the gums, the cementum that covers the root, the periodontal ligament and the aveolar bone. In the initial stage of periodontal disease, gingivitis, the infection affects only the gums. In more severe forms of the disease, all of the supporting tissues are involved. Periodontal disease if untreated results in chronic inflammation leading to insulin resistance, reduced glucose tolerance and risk of diabetes. People with diabetes are at a higher risk of getting periodontitis than people without diabetes. According to World Health Organization (WHO) globally, an estimated 422 million adults were living with diabetes in 2014, and is expected to double till 2025, and a large number of diabetic people in the world will be in emerging economies such as India and China. Hence, the increasing prevalence of diabetes is driving the global periodontal therapeutics market. On the basis of treatment, the global periodontal therapeutics market has been segmented in terms of systemic antibiotics and local antibiotics. Systemic antibiotics held the largest share due to product affordability, availability and high market penetration would further drive the periodontal therapeutics market during the forecast period.

In terms of geography, North America dominated the global periodontal therapeutics market in the base year 2016 due to the higher awareness regarding periodontal diseases as compared to other regions. Moreover, prevalence of periodontal diseases due to sedentary lifestyle, efficient reimbursement scenario and rising geriatric population are the major driving factors for the rise in the periodontal therapeutics market in North America. Asia Pacific has emerged as the most lucrative market for periodontal therapeutics market due to large patient pool, growing healthcare infrastructure and expenditure.

Market Competition Assessment

The periodontal therapeutics market currently possesses only few companies having their products marketed. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America. The companies include 3M, Valeant Pharmaceuticals, Inc., Kaken Pharmaceuticals Co. Ltd., Den-Mat Holdings, LLC, Dexcel Pharma and Galderma S.A.

Key Market Movements:
  • An increase in antibiotic-resistant bacteria has created interest in using inexpensive, safe, and highly bactericidal/virucidal antiseptics in periodontal therapy.
  • Rising geriatric population has resulted in the growth in the prevalence of periodontal diseases, which is boosting the demand for periodontal therapeutics gloabally.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Galderma S.A.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Periodontal Therapeutics Market Portraiture
2.2 Periodontal Therapeutics Market, by Treatment Type, 2016 (US$ Mn)
2.3 Periodontal Therapeutics Market, by Geography, 2016 (Value %)

Chapter 3 Global Periodontal Therapeutics Market Analysis
3.1 Global Periodontal Therapeutics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Periodontal Therapeutics Market, 2016 (Value %)

Chapter 4 Global Periodontal Therapeutics Market Analysis, By Therapeutic Type
4.1 Overview
4.1.1 Market Attractive Proposition of Periodontal Therapeutics Market, by Therapeutic Type, 2016
4.2 Systemic Antibiotics
4.2.1 Doxycycline
4.2.2 Minocycline
4.2.3 Metronidazole
4.2.4 Other Drugs
4.3 Local Antibodies
4.3.1 Arestin
4.3.2 Chlorhexidine
4.3.3 Other

Chapter 5 Global Periodontal Therapeutics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Periodontal Therapeutics Market, by Therapeutic Type, 2015-2025 (US$ Mn)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Periodontal Therapeutics Market, by Therapeutic Type, 2015-2025 (US$ Mn)
5.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
5.4.1 Asia Pacific Periodontal Therapeutics Market, by Therapeutic Type, 20152025 (US$ Mn)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Periodontal Therapeutics Market, by Therapeutic Type, 2015-2025 (US$ Mn)
5.6 Middle East and Africa
5.6.1 Middle East and Africa Periodontal Therapeutics Market, by Therapeutic Type, 2015-2025 (US$ Mn)

Chapter 6 Company Profiles
6.1 3M
6.2 Den-Mat Holdings, LLC
6.3 Dexcel Pharma
6.4 Galderma S.A.
6.5 Kaken Pharmaceutical Co., Ltd.
6.6 Valeant Pharmaceuticals International, Inc.

List of Figures
Fig. 1 Periodontal Therapeutics Market: Research Methodology
Fig. 2 Periodontal Therapeutics Market, by Therapeutic Type, 2016 (US$ Mn)
Fig. 3 Periodontal Therapeutics Market, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition
Fig. 5 Competitive Analysis: Global Periodontal Therapeutics Market, 2016 (Value %)
Fig. 6 Global Doxycycline Market(US$ Mn), 2015-2025
Fig. 7 Global Minocycline Market (US$ Mn), 2015-2025
Fig. 8 Global Metronidazole Market (US$ Mn), 2015-2025
Fig. 9 Global Other Drugs Market (US$ Mn), 2015-2025
Fig. 10 Global Arestin Market (US$ Mn), 2015-2025
Fig. 11 Global Chlorhexidine Market (US$ Mn), 2015-2025
Fig. 12 Global Other Market (US$ Mn), 2015-2025

List of Tables
Table 1 Global Periodontal Therapeutics Market, By Therapeutic Type (US$ Mn), 2015- 2025 (Value)
Table 2 Global Systemic Antibiotics Market(US$ Mn), 2015-2025
Table 3 Global Local Antibodies Market(US$ Mn), 2015-2025
Table 4 Global Periodontal Therapeutics Market, by Geography, 2015 - 2025 (US$ Mn)
Table 5 North America Periodontal Therapeutics Market, by Therapeutic Type, 2015 - 2025 (US$
Mn)
Table 6 North America Periodontal Therapeutics Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Europe Periodontal Therapeutics Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 8 Europe Periodontal Therapeutics Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Asia Pacific Periodontal Therapeutics Market, by Therapeutic Type, 2015 - 2025 (US$
Mn)
Table 10 Asia - Pacific Periodontal Therapeutics Market, by Country, 2015 - 2025 (US$ Mn)
Table 11 Latin America Periodontal Therapeutics Market, by Therapeutic Type, 2015 - 2025 (US$
Mn)
Table 12 Latin America Periodontal Therapeutics Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Middle East and Africa Periodontal Therapeutics Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 14 Middle East and Africa Periodontal Therapeutics Market, by Country, 2015 - 2025 (US$
Mn)
Table 15 3M: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
Table 16 Den-Mat Holdings, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 17 Dexcel Pharma: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 18 Galderma S.A.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 19 Kaken Pharmaceutical Co., Ltd.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 20 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description;
Financial Performance; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Galderma S.A.
  • Kaken Pharmaceutical Co., Ltd.
  • Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll